Animal & Vegan Advocacy Summit — General Support

Open Philanthropy recommended a grant of $550,000 over two years to Animal & Vegan Advocacy Summit for general support. Animal & Vegan Advocacy Summit is an independent project fiscally sponsored by ProVeg International, and runs a series of conferences for animal welfare advocates and organizations.

This follows our January 2024 support and falls within our focus area of farm animal welfare.

Fred Hutchinson Cancer Center — Fluro-BCG planning

Open Philanthropy recommended a gift of $102,000 to the Fred Hutchinson Cancer Center to support preparations and planning for a clinical trial to accelerate TB vaccine development. The research, led by Dr. Jim Kublin, will study a form of the BCG TB vaccine which has been modified to fluoresce (Fluor-BCG) so that bacteria can be visualized in human volunteers, providing dynamic measurement of vaccine-induced responses over time.

This falls within our focus area of scientific research.

Effective Ventures Foundation — Effective Giving Summit (November 2023)

Photo courtesy of the Effective Ventures Foundation

Open Philanthropy recommended a grant of $56,608.64 to support a summit in the UK bringing together representatives of organizations working on raising funds for effective charities. The grant will be administered by the Effective Ventures Foundation.

This falls within our focus area of empowering people to use their careers and donations to help others as much as possible.

Drugs & Diagnostics for Tropical Diseases — Rapid Diagnostic Tests

Image courtesy of Drugs & Diagnostics for Tropical Diseases

Open Philanthropy recommended a grant of $356,000 to Drugs & Diagnostics for Tropical Diseases to support the purchase of a semi-automated assembler — a piece of equipment that will allow them to manufacture diagnostic tests more rapidly and more affordably. These tests will be used in low- and middle-income countries, including in support of World Health Organization disease-eradication campaigns.

This falls within our focus area of global health R&D.